•   
  •   
  •   

Health & Fit FDA advisory panel recommends 2nd J&J shot for those 18 and over

13:41  16 october  2021
13:41  16 october  2021 Source:   today.com

7 Prebiotic Foods and How They Can Help Your Gut

  7 Prebiotic Foods and How They Can Help Your Gut If you want to add more prebiotic foods to your diet, here are some of the best prebiotic foods that dietitians recommend. The post 7 Prebiotic Foods and How They Can Help Your Gut appeared first on The Healthy.

A Food and Drug Administration advisory panel voted Friday to recommend a second Johnson & Johnson shot for emergency use authorization. The vote in favor was unanimous, with panel members citing the need to supplement protection in people who were vaccinated with the Johnson & Johnson shot . The decision will now go to the FDA , which is expected to make a final ruling in the coming days. The FDA doesn’t have to follow the guidance of the advisory panel , called the Vaccine and Related Biological Products Advisory Committee, although it usually does.

A Food and Drug Administration advisory panel voted Friday to recommend a second Johnson & Johnson shot for emergency use authorization. That ’s a departure from the recommendations for Pfizer-BioNTech and Moderna boosters, which are limited to those aged 65 and up, aged 18 to 64 with either underlying health conditions, or whose job that puts them at high risk of exposure to Covid-19. The recommended timing is also different: The Johnson & Johnson booster was authorized for at least two months after the initial vaccination, versus six months later for the Pfizer and Moderna vaccines.

A Food and Drug Administration advisory panel voted Friday to recommend a second Johnson & Johnson shot for emergency use authorization.

The vote in favor was unanimous, with panel members citing the need to supplement protection in people who were vaccinated with the Johnson & Johnson shot.

The decision will now go to the FDA, which is expected to make a final ruling in the coming days. The FDA doesn’t have to follow the guidance of the advisory panel, called the Vaccine and Related Biological Products Advisory Committee, although it usually does.

Authorization of Johnson & Johnson’s booster means that all of the available vaccines in the United States would have booster doses. Thursday, the same panel unanimously voted to recommend a Moderna booster for certain individuals.

Virus Experts Warn How Bad It Could Get

  Virus Experts Warn How Bad It Could Get "We have the capability to getting the end of this pandemic, very, very clearly by just [getting] vaccinated,” said Dr. Anthony Fauci.

The panel recommended the boosters to everyone 18 and over who's already received J & J 's first shot at least two months after the initial dose. Many committee members said it should be considered a two -dose vaccine much like Moderna and Pfizer's. FDA officials acknowledged during their presentations before the panel that J & J 's trials were completed with small sample groups of participants, making it difficult to draw conclusions on the data. Dr. Peter Marks, the agency's top vaccine regulator, asked that the panel move forward with the meeting and address any members'

A Food and Drug Administration advisory panel voted Friday to recommend a second Johnson & Johnson shot for emergency use authorization. The vote in favor was unanimous, with panel members citing the need to supplement protection in people who were vaccinated with the Johnson & Johnson shot . That ’s a departure from the recommendations for Pfizer-BioNTech and Moderna boosters, which are limited to those aged 65 and up, aged 18 to 64 with either underlying health conditions, or whose job that puts them at high risk of exposure to Covid-19. The recommended timing is also

Related: The decision will now go to the Food and Drug Administration, which is expected to make a final ruling in the coming days.

The Johnson & Johnson booster would be available for all of the nearly 15 million people ages 18 and up who received that vaccine. That’s a departure from the recommendations for Pfizer-BioNTech and Moderna boosters, which are limited to those aged 65 and up, aged 18 to 64 with either underlying health conditions, or whose job that puts them at high risk of exposure to COVID-19.

The recommended timing is also different: The Johnson & Johnson booster was authorized for at least two months after the initial vaccination, versus six months later for the Pfizer and Moderna vaccines.

The vote came two days after a highly anticipated study from the National Institutes of Health found that giving people who received the Johnson & Johnson vaccine a booster shot of Moderna or Pfizer led to higher antibody levels than boosting with a second Johnson & Johnson dose. That data will be a topic of discussion at the committee meeting later Friday afternoon.

Peanut butter and jelly: Facts about this American classic

  Peanut butter and jelly: Facts about this American classic The humble peanut butter and jelly sandwich has a huge back story and some out-of-this-world fans. Find out when it got its official start and the right and wrong way to make one.

Available data support the safety and effectiveness of the Johnson & Johnson COVID-19 vaccine for emergency use authorization as a booster dose in individuals aged 18 and older at least two months after an initial single dose, the Food and Drug Administration’s Vaccines and Related Biological The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices will consider the recommendations next week. FDA last month amended Pfizer’s emergency use authorization for its COVID-19 vaccine to allow for an additional, booster dose for certain individuals.

A key federal advisory committee voted unanimously Friday to recommend emergency authorization of an additional shot for all recipients of Johnson & Johnson’s COVID-19 vaccine at least two months after their initial dose, a sign that 15 million Americans will likely be cleared for a second J & J inoculation as soon as next weekend. If implemented, the recommendation from the Food and Drug Administration’s expert panel would effectively transform Johnson & Johnson from its original formulation as “one and done” vaccine into a two -dose series akin to those produced by Pfizer and

Wednesday, in the run-up to Friday’s meeting, the FDA offered a critical view of Johnson & Johnson’s submission for a booster dose, noting shortcomings in the data.

On Friday, the committee agreed that a second dose was warranted, particularly given the lower effectiveness of the single shot. The results of Johnson & Johnson’s Phase 3 study, in which people received a booster shot 2 months after their initial vaccination, found that the additional dose increased the effectiveness to 94%.

In fact, many committee members argued that Johnson & Johnson’s vaccination regime should simply be considered a two-dose vaccine, just like the Pfizer and Moderna vaccines, rather than a single shot plus a booster.

“I’m inclined to just consider this a two-dose vaccine. That’s how it should probably go forward,” said committee member Dr. Michael Kurilla, an infectious disease expert with the National Institutes of Health.

9 Hiking Sandals for Women That Your Feet Will Love

  9 Hiking Sandals for Women That Your Feet Will Love Hiking is a safe and fun way to get some exercise—as long as you've got the right gear. Here's what the experts want you to know when shopping for hiking sandals for women. The post 9 Hiking Sandals for Women That Your Feet Will Love appeared first on The Healthy.

The advisers unanimously voted that those who got the one-dose vaccine should get a booster at least two months later. The J & J vaccine was approved earlier this year for emergency use authorization for people 18 years and older. The FDA generally follows the recommendations of the vaccine advisory panel . Later Friday, the panel is expected to hear a presentation from the National Institute of Health's National Institute of Allergy and Infectious Diseases on its "mix and match" booster study.

A group of Food and Drug Administration advisers on Friday unanimously recommended that all adult Johnson & Johnson COVID-19 vaccine recipients get a booster shot at least two months after the first shot , joining Pfizer and Moderna in gaining a recommendation for an additional dose. © (Wilfredo Lee/AP-File) FILE - This May 13, 2021, file photo shows syringes filled with the Johnson & Johnson vaccine at a mobile vaccination site in Miami. Starting Thursday, Oct.

At the same time, Johnson & Johnson tried to make the case that their single dose remained effective.

That drew particularly pointed criticism from the FDA. Dr. Peter Marks, the director of the agency’s Center for Biologics Evaluation and Research, went as far as to suggest that the company was not presenting the full picture, particularly in terms of the real-world effectiveness of a single dose.

In its phase 3 clinical trial in the U.S., the Johnson & Johnson vaccine was shown to be 72% effective against moderate to severe illness — lower than the roughly 95% effectiveness seen in the Pfizer and Moderna clinical trials. However, the company said that the effectiveness remained stable and did not wane in the eight months following vaccination.

Dr. Dan Barouch, director of the center for virology and vaccine research at Beth Israel Deaconess Medical Center in Boston, who presented on behalf of Johnson & Johnson, said that antibody tests to the delta, alpha, and beta variants "show substantial decline over time for the mRNA vaccines," or Moderna and Pfizer, while the antibody test to these variants were generally stable for the Johnson & Johnson vaccine.

Coconut Cream vs. Coconut Milk: What’s the Difference?

  Coconut Cream vs. Coconut Milk: What’s the Difference? When it comes to these two vegan standbys, which should be your go-to? Nutritionists explain the difference between coconut milk and coconut cream. The post Coconut Cream vs. Coconut Milk: What’s the Difference? appeared first on The Healthy.

Marks, however, said that “there are data that suggests the effectiveness of this vaccine is actually less robust than the company’s presentation here.”

Dr. Amanda Cohn, chief medical officer on the Centers for Disease Control and Prevention’s COVID-19 Vaccine Task Force, said that the agency’s data has found that “the effectiveness or protection with a single dose of the J&J vaccine is not equivalent to protection, at this time, with either two doses of an mRNA vaccine, and certainly not in those groups who have now been authorized to receive a booster dose of an mRNA vaccine.”

Related:

Indeed, the rate of breakthrough cases and deaths were higher for Johnson & Johnson recipients than recipients of the other vaccines, according to CDC data.

The lower effectiveness of the single shot points to the need for an additional dose, said Dr. Arnold Monto, acting chair of the committee.

“There is a public health imperative here, because what we’re seeing is that this is a group with overall lower efficacy than we have seen with the mRNA vaccine so there is some urgency to do something,” he said.

The Johnson & Johnson vaccine has not been without controversy. In April, the FDA and Centers for Disease Control and Prevention ordered that vaccinations be paused as they investigated several cases of rare but serious blood clots tied to the vaccine. Over the summer, the FDA added a warning label that the shot could raise the risk of a neurological disorder called Guillain-Barre syndrome.

Manufacturing problems have also hobbled the vaccine rollout. Just under 15 million people in the U.S. have been fully vaccinated with Johnson & Johnson, compared to more than 100 million for Pfizer and nearly 70 million for Moderna.

This story originally appeared on NBCNews.com.

Everything to Know About the FDA's New Guidance to Drastically Limit Salt In Food .
The agency notes that the average sodium intake in the U.S. is approximately 3,400 milligrams (!!!) per day. How the New Sodium Reduction Guidelines Will Help Currently, about 70 percent of the U.S. population's sodium intake comes from processed and packaged food, in addition to meals served at restaurants, according to recent research published by the American Heart Association.

usr: 0
This is interesting!